A Look at Adaptive Biotechnologies Corp (ADPT) Shares in the Recent Past Indicates Growth

With 0.88 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.59 shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $3.7988 whereas the lowest price it dropped to was $3.6450. The 52-week range on ADPT shows that it touched its highest point at $10.38 and its lowest point at $2.61 during that stretch. It currently has a 1-year price target of $8.67. Beta for the stock currently stands at 1.25.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ADPT was up-trending over the past week, with a rise of 3.56%, but this was down by -21.25% over a month. Three-month performance dropped to -16.19% while six-month performance fell -41.12%. The stock lost -56.95% in the past year, while it has lost -22.86% so far this year. A look at the trailing 12-month EPS for ADPT yields -1.36 with Next year EPS estimates of -1.16. For the next quarter, that number is -0.33. This implies an EPS growth rate of -0.91% for this year and 18.13% for next year. EPS is expected to grow by 21.60% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -32.30%.

Float and Shares Shorts:

At present, 143.11 million ADPT shares are outstanding with a float of 141.49 million shares on hand for trading. On Jan 31, 2024, short shares totaled 8.81 million, which was 6.09% higher than short shares on Dec 29, 2023. In addition to Mr. Chad M. Robins M.B.A. as the firm’s Co-Founder, CEO & Chairman, Ms. Julie Rubinstein serves as its President & COO.

Institutional Ownership:

Through their ownership of 97.46% of ADPT’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ADPT since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ADPT analysts setting a high price target of $11.00 and a low target of $6.00, the average target price over the next 12 months is $8.67. Based on these targets, ADPT could surge 191.01% to reach the target high and rise by 58.73% to reach the target low. Reaching the average price target will result in a growth of 129.37% from current levels.

Summary of Insider Activity:

Insiders traded ADPT stock several times over the past three months with 0 Buys and 1 Sells. In these transactions, 0 shares were bought while 259 shares were sold. The number of buy transactions has increased to 19 while that of sell transactions has risen to 22 over the past year. The total number of shares bought during that period was 1,782,855 while 368,686 shares were sold.